What is BNTC's current stock price?

As of now, BNTC is trading at $13.16, with a daily change of -2.73%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

BNTC Stock Analysis & IQ Rating | Benitec Biopharma

BNTC

Benitec Biopharma

$13.16

-$0.37 | -2.73%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$17.15

MKT CAP

$449.01M

52W Low

$9.49

VOL

$114.61K

P/E Ratio

N/A

AVG VOL

$232.46K

RSI

42.44

TREND

Sideways

BNTC Stock IQ

Login to see Benitec Biopharma (BNTC) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

BNTC Target Price

Login to display

Strengths

BNTC Rewards

Upgraded on attractively valued

BNTC Rewards

Outperform the market

Chart

$15.7 (-16.18%)

$13.21 (-0.38%)

$11.35 (+15.95%)

$9.76 (+34.84%)

1year

6month

3month

1month

BNTC Risk Level

BNTC has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Low volume

Low

LOW

HIGH

BNTC Analysts Opinion

BNTC overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

BNTC Analysts Opinion

BNTC Analysts opinion is positive and also has improved from the past 3 months

BNTC Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

85%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

NA

67%

BNTC Street Sentiment

BNTC Street Sentiment is extremely bullish and have positive views on the near-term outlook

BNTC Performance Sentiment

Sentiments overview associated with BNTC events and the stock performance.

85%

15%

Positive

Negative

17 out of 20
events present

3 out of 20
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$13.10

Resistance
Price

N/A

Current Price Range

$16.52

Show methods +

BNTC Latest Analysis +

Citizens Lifts Benitec Biopharma Inc. (BNTC) Price Target on Topline Results for Oculopharyngeal Muscular Dystrophy Treatment. Benitec Biopharma Inc. (NASDAQ:BNTC) is one of the best breakout stocks to invest in. On November 4 an analyst at Citizens JMP raised the stocks price target to $22 from $20 while reiterating an Outperform rating. The price target hike follows topline clinical data results that showed a 100% response rate for BB-301 in Phase [….]

Tue Nov 18, 2025

$13.53 | 0.00%

Activity

Potential

Benitec Biopharmas SWOT analysis: gene therapy stock shows promise amid sector headwinds.

Tue Nov 18, 2025

$13.53 | 0.00%

Activity

Potential

Benitec Biopharma Releases First Quarter 2026 Financial Results and Provides Operational Update. –Fast Track Designation was granted for BB-301 following United States Food and Drug Administration (FDA) review of positive interim clinical study results and proprietary Responder Analysis planned for use in pivotal study for BB-301–

Fri Nov 14, 2025

$13.10 | +0.08%

Activity

Benitec Biopharma prices $100M stock offering.

Thu Nov 6, 2025

$12.00 | -23.95%

Activity

Benitec Biopharma Inc. Announces Pricing of $100 Million Common Stock Offering. ) (Benitec or the Company) a clinical-stage gene therapy-focused biotechnology company developing novel genetic medicines based on its proprietary DNA- directed RNA interference (ddRNAi) Silence and Replace platform today announced the pricing of its underwritten public offering of 5930000 shares of its common stock and a concurrent registered direct offering of 1481481 shares of its common stock with long-term inves

Thu Nov 6, 2025

$12.00 | -23.95%

Activity

Benitec Biopharma launches public registered direct offerings.

Wed Nov 5, 2025

$15.78 | +0.32%

Activity

Benitec Biopharma Inc. Announces Proposed Public Offering. HAYWARD Calif. Nov. 05 2025 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (Nasdaq: BNTC) (Benitec or the Company) a clinical-stage gene therapy-focused biotechnology company developing novel genetic medicines based on its proprietary DNA- directed RNA interference (ddRNAi) Silence and Replace platform today announced that it has commenced an underwritten public offering of its common stock (or pre-funded warrants to purchase common stock in

Wed Nov 5, 2025

$15.78 | +0.32%

Activity

HC Wainwright & Co. Maintains Benitec Biopharma (BNTC) Buy Recommendation. Fintel reports that on November 4 2025 HC Wainwright &. Co. maintained coverage of Benitec Biopharma (NasdaqCM:BNTC) with a Buy recommendation. Analyst Price Forecast Suggests 69.57% Upside

Wed Nov 5, 2025

$15.78 | +0.32%

Rating

Citizens Maintains Benitec Biopharma (BNTC) Market Outperform Recommendation. Fintel reports that on November 4 2025 Citizens maintained coverage of Benitec Biopharma (NasdaqCM:BNTC) with a Market Outperform recommendation. Analyst Price Forecast Suggests 69.57% Upside

Wed Nov 5, 2025

$15.78 | +0.32%

Potential

Rating

Benitec Biopharma to Provide Phase 1b/2a Clinical Study Update for BB-301 in Oculopharyngeal Muscular Dystrophy. ) (Benitec or the Company) a clinical-stage gene therapy-focused biotechnology company developing novel genetic medicines based on its proprietary Silence and Replace DNA-directed RNA interference (ddRNAi) platform today announced that it will provide an update on the six treated patients from Cohort 1 of its Phase 1b/2a Clinical Study of BB-301 being investigated ...

Mon Nov 3, 2025

$15.86 | -3.06%

Activity

FAQ About BNTC Stock Insights

What is BNTC current stock price?

What are BNTC stock strengths?

What is BNTC Risk Level?

What is BNTC market cap and volume?

What is BNTC current Stock IQ?

Should I buy BNTC stock right now?

Is BNTC a Strong Buy right now?

What does a 'Strong Buy' rating mean for BNTC?

What does a 'Strong Sell' rating mean for BNTC?

What factors influence BNTC's Stock IQ?

Explore our BNTC Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored BNTC Stock Strategies
Effective Risk Management

FIND US ON

Receive our BNTC Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

BNTC

Benitec Biopharma

Current Price

$13.16

-$0.37 | -2.73%

52W High

$17.15

MKT CAP

$449.01M

52W Low

$9.49

VOL

$114.61K

P/E Ratio

N/A

AVG VOL

$232.46K

RSI

42.44

TREND

Sideways

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

BNTC Rewards

Upgraded on attractively valued

BNTC Rewards

Outperform the market

BNTC Stock IQ

Login to unlock Benitec Biopharma (BNTC) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$15.7 (-16.18%)

$13.21 (-0.38%)

$11.35 (+15.95%)

$9.76 (+34.84%)

1year

6month

3month

1month

BNTC Analysts Opinion

BNTC Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

BNTC Analysts Opinion

BNTC Analysts opinion is positive and also has improved from the past 3 months

BNTC Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

85%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

NA

67%

BNTC Street Sentiment

BNTC Street Sentiment is extremely bullish and have positive views on the near-term outlook

BNTC Risk Level

BNTC has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Low volume

Low

LOW

HIGH

BNTC Performance Sentiment

Sentiments overview associated with BNTC events and the stock performance.

85%

15%

Positive

Negative

17 out of 20
events present

3 out of 20
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$13.10

Resistance
Price

N/A

Current Price Range

$16.52

Show methods +

BNTC Latest Analysis

Citizens Lifts Benitec Biopharma Inc. (BNTC) Price Target on Topline Results for Oculopharyngeal Muscular Dystrophy Treatment. Benitec Biopharma Inc. (NASDAQ:BNTC) is one of the best breakout stocks to invest in. On November 4 an analyst at Citizens JMP raised the stocks price target to $22 from $20 while reiterating an Outperform rating. The price target hike follows topline clinical data results that showed a 100% response rate for BB-301 in Phase [….]

Tue Nov 18, 2025

$13.53 | 0.00%

Activity

Potential

Benitec Biopharmas SWOT analysis: gene therapy stock shows promise amid sector headwinds.

Tue Nov 18, 2025

$13.53 | 0.00%

Activity

Potential

Benitec Biopharma Releases First Quarter 2026 Financial Results and Provides Operational Update. –Fast Track Designation was granted for BB-301 following United States Food and Drug Administration (FDA) review of positive interim clinical study results and proprietary Responder Analysis planned for use in pivotal study for BB-301–

Fri Nov 14, 2025

$13.10 | +0.08%

Activity

Benitec Biopharma prices $100M stock offering.

Thu Nov 6, 2025

$12.00 | -23.95%

Activity

Benitec Biopharma Inc. Announces Pricing of $100 Million Common Stock Offering. ) (Benitec or the Company) a clinical-stage gene therapy-focused biotechnology company developing novel genetic medicines based on its proprietary DNA- directed RNA interference (ddRNAi) Silence and Replace platform today announced the pricing of its underwritten public offering of 5930000 shares of its common stock and a concurrent registered direct offering of 1481481 shares of its common stock with long-term inves

Thu Nov 6, 2025

$12.00 | -23.95%

Activity

Benitec Biopharma launches public registered direct offerings.

Wed Nov 5, 2025

$15.78 | +0.32%

Activity

Benitec Biopharma Inc. Announces Proposed Public Offering. HAYWARD Calif. Nov. 05 2025 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (Nasdaq: BNTC) (Benitec or the Company) a clinical-stage gene therapy-focused biotechnology company developing novel genetic medicines based on its proprietary DNA- directed RNA interference (ddRNAi) Silence and Replace platform today announced that it has commenced an underwritten public offering of its common stock (or pre-funded warrants to purchase common stock in

Wed Nov 5, 2025

$15.78 | +0.32%

Activity

HC Wainwright & Co. Maintains Benitec Biopharma (BNTC) Buy Recommendation. Fintel reports that on November 4 2025 HC Wainwright &. Co. maintained coverage of Benitec Biopharma (NasdaqCM:BNTC) with a Buy recommendation. Analyst Price Forecast Suggests 69.57% Upside

Wed Nov 5, 2025

$15.78 | +0.32%

Rating

Citizens Maintains Benitec Biopharma (BNTC) Market Outperform Recommendation. Fintel reports that on November 4 2025 Citizens maintained coverage of Benitec Biopharma (NasdaqCM:BNTC) with a Market Outperform recommendation. Analyst Price Forecast Suggests 69.57% Upside

Wed Nov 5, 2025

$15.78 | +0.32%

Potential

Rating

Benitec Biopharma to Provide Phase 1b/2a Clinical Study Update for BB-301 in Oculopharyngeal Muscular Dystrophy. ) (Benitec or the Company) a clinical-stage gene therapy-focused biotechnology company developing novel genetic medicines based on its proprietary Silence and Replace DNA-directed RNA interference (ddRNAi) platform today announced that it will provide an update on the six treated patients from Cohort 1 of its Phase 1b/2a Clinical Study of BB-301 being investigated ...

Mon Nov 3, 2025

$15.86 | -3.06%

Activity

Discover BNTC Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of BNTC. We're here to help you make informed investment decisions today.

FIND US ON

Receive our BNTC Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

BNTC Stock trends

BNTC Stock performance

BNTC Stock analysis

BNTC investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing BNTC

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing BNTC

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

BNTC Stock Analysis & IQ Rating | Benitec Biopharma

BNTC Stock IQ

BNTC Target Price

BNTC Risk Level

BNTC Analysts Opinion

BNTC Street Sentiment

BNTC Performance Sentiment

Technical Price Levels

Explore our BNTC Stock insights

Receive our BNTC Daily Alerts

BNTC Stock IQ

BNTC Street Sentiment

BNTC Risk Level

Technical Price Levels

Discover BNTC Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of BNTC. We're here to help you make informed investment decisions today.

Receive our BNTC Daily Alerts

BNTC Runner Alarm